Guardion Health Sciences Inc - Understand $ghsi stock

$GHSI Market Cap: $13.45 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$9.346M

TTM

Gross Margin

44.72%

TTM

Net Earnings

$6.375M

TTM

Current Assets

$15.29M

Q2 2024

Current Liabilities

$917.3K

Q2 2024

Current Ratio

1667.04%

Q2 2024

Total Assets

$15.30M

Q2 2024

Total Liabilities

$1.549M

Q2 2024

Book Value

$13.75M

Q2 2024

Cash

$14.82M

Q2 2024

P/E

2.109

Sep 18, 2024 EST

Free Cash Flow

-$2.838M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Revenue	$12.25M	$11.05M	$7.233M	$1.890M	$900.0K	$942.2K	$437.3K	$141.0K	$112.8K	$160.0K	$260.0K
YoY Change	10.85%	52.77%	282.7%	110.0%	-4.47%	115.42%	210.11%	25.01%	-29.49%	-38.46%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Revenue	$12.25M	$11.05M	$7.233M	$1.890M	$900.0K	$942.2K	$437.3K	$141.0K	$112.8K	$160.0K	$260.0K
Cost Of Revenue	$6.854M	$6.529M	$4.123M	$1.330M	$340.0K	$398.2K	$175.5K	$75.70K	$50.07K	$150.0K	$170.0K
Gross Profit	$5.395M	$4.520M	$3.110M	$560.0K	$560.0K	$544.0K	$261.9K	$65.33K	$62.74K	$20.00K	$90.00K
Gross Profit Margin	44.04%	40.91%	43.0%	29.63%	62.22%	57.74%	59.88%	46.32%	55.61%	12.5%	34.62%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Selling, General & Admin	$9.166M	$11.65M	$13.48M	$8.870M	$9.260M	$6.456M	$5.284M	$3.728M	$5.791M	$670.0K	$660.0K
YoY Change	-21.3%	-13.57%	51.93%	-4.21%	43.44%	22.18%	41.73%	-35.62%	764.32%	1.52%
% of Gross Profit	169.92%	257.67%	433.25%	1583.93%	1653.57%	1186.79%	2017.67%	5706.98%	9230.24%	3350.0%	733.33%
Research & Development	$150.7K	$193.8K	$26.25K	$130.0K	$160.0K	$231.8K	$259.5K	$33.08K	$401.9K	$10.00K	$260.0K
YoY Change	-22.25%	638.29%	-79.81%	-18.75%	-30.99%	-10.64%	684.26%	-91.77%	3919.09%	-96.15%
% of Gross Profit	2.79%	4.29%	0.84%	23.21%	28.57%	42.62%	99.08%	50.64%	640.6%	50.0%	288.89%
Depreciation & Amortization	$19.42K	$58.79K	$782.9K	$70.00K	$480.0K	$300.0K	$120.0K	$60.00K	$50.00K	$40.00K	$10.00K
YoY Change	-66.97%	-92.49%	1018.46%	-85.42%	60.0%	150.0%	100.0%	20.0%	25.0%	300.0%
% of Gross Profit	0.36%	1.3%	25.17%	12.5%	85.71%	55.15%	45.82%	91.85%	79.7%	200.0%	11.11%
Operating Expenses	$9.336M	$21.94M	$13.59M	$9.060M	$9.500M	$6.688M	$5.543M	$4.011M	$6.451M	$720.0K	$930.0K
YoY Change	-57.45%	61.4%	50.04%	-4.63%	42.05%	20.64%	38.2%	-37.83%	796.04%	-22.58%
Operating Profit	-$3.942M	-$17.42M	-$10.48M	-$8.500M	-$8.940M	-$6.144M	-$5.281M	-$3.946M	-$6.389M	-$700.0K	-$840.0K
YoY Change	-77.37%	66.17%	23.33%	-4.92%	45.51%	16.33%	33.85%	-38.24%	812.68%	-16.67%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Interest Expense	$4.364M	$2.498M		-$20.00K	$30.00K	$2.289K	$23.73K	$1.105M	$752.9K	-$610.0K	-$410.0K
YoY Change	74.69%			-166.67%	1210.62%	-90.35%	-97.85%	46.7%	-223.43%	48.78%
% of Operating Profit
Other Income/Expense, Net	$4.494M	$2.498M	$1.797K	$0.00	-$420.0K	-$1.624M	-$23.73K	-$700.0K	-$1.700M
YoY Change	79.89%	138930.05%		-100.0%	-74.13%	6743.2%	-96.61%	-58.82%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Pretax Income	$158.0K	-$14.92M	-$24.75M	-$8.570M	-$10.88M	-$7.770M	-$5.310M	-$5.750M	-$8.840M	-$1.320M	-$1.240M
YoY Change	-101.06%	-39.7%	188.74%	-21.23%	40.03%	46.33%	-7.65%	-34.95%	569.7%	6.45%
Income Tax
% Of Pretax Income
Net Earnings	$158.0K	-$14.92M	-$24.75M	-$8.570M	-$10.88M	-$7.767M	-$5.305M	-$5.748M	-$8.841M	-$1.320M	-$1.240M
YoY Change	-101.06%	-39.7%	188.74%	-21.23%	40.07%	46.41%	-7.71%	-34.98%	569.8%	6.45%
Net Earnings / Revenue	1.29%	-135.05%	-342.11%	-453.44%	-1208.89%	-824.43%	-1213.03%	-4076.04%	-7837.26%	-825.0%	-476.92%
Basic Earnings Per Share	$0.12	-$14.15	-$52.23
Diluted Earnings Per Share	$0.12	-$14.15	-$1.045M	-$601.0K	-$1.789M	-$2.313M	-$1.144M	-$1.584M	-$2.130M	-$322.0K	-$302.4K

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Cash & Short-Term Investments	$6.360M	$15.91M	$9.090M	$8.520M	$11.12M	$670.0K	$4.740M	$60.00K	$10.00K	$10.00K	$20.00K
YoY Change	-60.02%	74.99%	6.68%	-23.38%	1559.7%	-85.86%	7800.0%	500.0%	0.0%	-50.0%
Cash & Equivalents	$6.360M	$15.91M
Short-Term Investments		$0.00	$4.996M
Other Short-Term Assets	$573.8K	$687.9K	$1.200M	$180.0K	$360.0K	$50.00K	$120.0K	$30.00K	$20.00K	$10.00K	$10.00K
YoY Change	-16.59%	-42.69%	566.88%	-50.0%	620.0%	-58.33%	300.0%	50.0%	100.0%	0.0%
Inventory	$2.677M	$3.119M	$367.7K	$380.0K	$310.0K	$360.0K	$150.0K	$40.00K	$30.00K	$20.00K	$90.00K
Prepaid Expenses
Receivables	$2.274M	$1.924M	$1.412M	$10.00K	$80.00K	$30.00K	$70.00K	$0.00	$0.00	$0.00	$0.00
Other Receivables	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$60.00K
Total Short-Term Assets	$11.88M	$21.64M	$12.07M	$9.090M	$11.87M	$1.100M	$5.080M	$140.0K	$60.00K	$40.00K	$180.0K
YoY Change	-45.07%	79.28%	32.77%	-23.42%	979.09%	-78.35%	3528.57%	133.33%	50.0%	-77.78%
Property, Plant & Equipment	$33.25K	$48.87K	$135.6K	$700.0K	$950.0K	$270.0K	$100.0K	$110.0K	$170.0K	$210.0K	$250.0K
YoY Change	-31.96%	-63.97%	-80.62%	-26.32%	251.85%	170.0%	-9.09%	-35.29%	-19.05%	-16.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets			$0.00	$10.00K	$10.00K	$280.0K	$10.00K	$10.00K	$10.00K	$20.00K	$30.00K
YoY Change			-100.0%	0.0%	-96.43%	2700.0%	0.0%	0.0%	-50.0%	-33.33%
Total Long-Term Assets	$33.25K	$48.87K	$11.39M	$770.0K	$1.010M	$2.580M	$2.290M	$120.0K	$190.0K	$230.0K	$280.0K
YoY Change	-31.96%	-99.57%	1379.41%	-23.76%	-60.85%	12.66%	1808.33%	-36.84%	-17.39%	-17.86%
Total Assets	$11.92M	$21.69M	$23.46M	$9.860M	$12.88M	$3.680M	$7.370M	$260.0K	$250.0K	$270.0K	$460.0K
YoY Change
Accounts Payable	$614.1K	$1.518M	$241.4K	$610.0K	$130.0K	$410.0K	$310.0K	$360.0K	$270.0K	$200.0K	$240.0K
YoY Change	-59.55%	528.98%	-60.43%	369.23%	-68.29%	32.26%	-13.89%	33.33%	35.0%	-16.67%
Accrued Expenses	$704.9K	$562.1K	$917.7K	$290.0K	$270.0K	$80.00K	$10.00K	$90.00K	$140.0K	$160.0K	$70.00K
YoY Change	25.41%	-38.75%	216.45%	7.41%	237.5%	700.0%	-88.89%	-35.71%	-12.5%	128.57%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$30.00K	$0.00	$0.00	$0.00	$0.00
YoY Change						-100.0%
Long-Term Debt Due							$0.00	$70.00K	$250.0K	$1.180M	$110.0K
YoY Change							-100.0%	-72.0%	-78.81%	972.73%
Total Short-Term Liabilities	$1.319M	$4.012M	$1.159M	$1.070M	$410.0K	$500.0K	$500.0K	$610.0K	$960.0K	$1.600M	$420.0K
YoY Change	-67.12%	246.11%	8.32%	160.98%	-18.0%	0.0%	-18.03%	-36.46%	-40.0%	280.95%
Long-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$520.0K	$490.0K	$940.0K
YoY Change								-100.0%	6.12%	-47.87%
Other Long-Term Liabilities	$2.453M	$4.507M	$3.810K	$270.0K	$430.0K
YoY Change	-45.57%	118183.46%	-98.59%	-37.21%
Total Long-Term Liabilities	$2.453M	$4.507M	$3.810K	$270.0K	$430.0K	$0.00	$0.00	$0.00	$520.0K	$490.0K	$940.0K
YoY Change	-45.57%	118183.46%	-98.59%	-37.21%				-100.0%	6.12%	-47.87%
Total Liabilities	$3.772M	$8.518M	$1.163M	$1.350M	$840.0K	$500.0K	$500.0K	$610.0K	$1.470M	$2.090M	$1.360M
YoY Change	-55.72%	632.52%	-13.86%	60.71%	68.0%	0.0%	-18.03%	-58.5%	-29.67%	53.68%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021
Basic Shares Outstanding	1.271M shares	1.121M shares	473.8K shares
Diluted Shares Outstanding	1.271M shares	1.121M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Dividends

Stock Price

Market Cap: $13.445 Million

About Guardion Health Sciences Inc

Guardion Health Sciences, Inc. engages in the business of developing and distributing clinically supported nutrition, medical foods, and dietary supplements. The company is headquartered in Houston, Texas and currently employs 9 full-time employees. The company went IPO on 2019-04-05. The firm offers a portfolio of science-based, clinically supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients. The firm sells two ocular products: GlaucoCetin and Lumega-Z. GlaucoCetin is a dietary supplement in a capsule form designed specifically to provide nutrients to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health. Lumega-Z, its medical food product, has a formula designed to replenish and restore the macular protective pigment, simultaneously delivering critical and essential nutrients to the eye. As a medical food, Lumega-Z must be administered under the supervision of a physician or professional healthcare provider. The company sells GlaucoCetin and Lumega-Z on its Website, guardionhealth.com.

Industry: Pharmaceutical Preparations Peers: Smart for Life Inc CV Sciences Inc ESTEE LAUDER COMPANIES INC Genufood Energy Enzymes Corp Kona Gold Beverage Inc LiveWire Ergogenics, Inc. RELIV INTERNATIONAL INC